Trials / Completed
CompletedNCT01256320
Egg Study With Peripheral Arterial Disease
The Impact of Egg Consumption on Indices of Vascular Health in Individuals With Peripheral Arterial Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- University of Manitoba · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The current research study has the potential to generate data that would provide solid clinical endpoints as to the impact of including eggs in a regular diet in individuals with peripheral arterial disease. Any one of three potential outcomes may be observed as a result of this study, and they are predicted as follows: 1) Egg consumption does not lead to a deterioration of indices of cardiovascular health; 2) Egg consumption improves indices of cardiovascular health; 3) Egg consumption worsens the indices of cardiovascular health.
Detailed description
Given the hypotheses proposed, if either of the first two predictions prove to be positive, they will help encourage directive efforts to be made toward effective nutrition messages for egg consumption in the peripheral arterial disease and the healthy population. If the last prediction is positive, while least favourable, it will still establish important information to assist the industry in their efforts toward establishing population-specific nutrition messaging.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Classic Egg Group | consumption of 6 eggs/week (1 egg/day for 6 days with 1 day rest) of commercial classic eggs |
| OTHER | Omega 3 Egg Group | consumption of 6 eggs/week (1 egg/day for 6 days with 1 day rest) of commercial Omega-3 eggs |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2012-12-01
- Completion
- 2013-02-01
- First posted
- 2010-12-08
- Last updated
- 2017-05-04
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01256320. Inclusion in this directory is not an endorsement.